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ABSTRACT  
25 selenoproteins that contain selenium, incorporated as selenocysteine (Sec), have been iden-
tified to date. Selenoprotein M (SELM) is one of seven endoplasmic reticulum (ER)-resident, 
Sec-containing proteins that may be involved in posttranslational processing of proteins and 
maintenance of ER function. Since SELM was overrepresented in a cartilage- and bone-
specific expressed sequence tag (EST) library, we further investigated the expression pattern 
of Selm and its possible biological function in the skeleton. RNA in situ hybridization of Selm 
in chicken and mice of different developmental stages revealed prominent expression in 
bones, specifically in osteoblast, and in tendons. This result suggests that SELM functions 
during bone development, where it is possibly involved in the processing of secreted proteins. 
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INTRODUCTION 
Selenium is an essential trace element 
that plays an important role in several met-
abolic pathways, including thyroid hormone 
metabolism, antioxidant defense system, 
and intracellular redox homeostasis 
(Gromer et al., 2005). Moreover, selenium 
has been shown to be incorporated as sele-
nocysteine (Sec) into at least 25 human and 
24 rodent selenoproteins identified so far 
(Behne and Kyriakopoulos, 2001; Kryukov 
et al., 2003; Reeves and Hoffmann, 2009). 
Sec is encoded by the UGA codon, and 
recognition of this 21st amino acid is en-
sured by a stem-loop structure in the 3′ 
UTR termed the Sec insertion sequence 
(SECIS) (Driscoll and Copeland, 2003). 
Although their precise biological functions 
remain unknown, recent data suggest that 
endoplasmic reticulum (ER)-resident sele-
noproteins form an important part of the ER 
quality control machinery (Labunskyy et 
al., 2007) and may be involved in the for-
mation or isomerization of disulfide bonds 
and in the unfolded protein response (UPR) 
(Hawkes and Alkan, 2010). The correct 
folding of proteins is essential for ER func-
tion and plays a fundamental role in the se-
cretory pathway. Accumulation of misfold-
ed or unfolded proteins in the ER results in 
ER stress, which leads to translational at-
tenuation, transcriptional activation of 
chaperones, and protein degradation 
(Schroder and Kaufman, 2005).  
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Selenoproteins are crucial for embryo-
genesis as targeted deletion of the Sec 
tRNA gene, Trsp, which is responsible for 
the expression of all selenoproteins, is em-
bryonic lethal (Downey et al., 2009). Fur-
thermore, Col2a1 promoter-driven condi-
tional knockout in osteochondroprogenitor 
cells revealed essential functions of seleno-
proteins in bone development. This corre-
sponds to observations suggesting that bone 
tissue in man and rat is affected by seleni-
um deficiency (Tsukahara et al., 1996; 
Moreno-Reyes et al., 2001). Moreover, se-
lenium deficiency may also play a role in 
Kashin-Beck osteoarthropathy, endemic in 
China and Tibet (Moreno-Reyes et al., 
1998).  
SELM is an ER-resident selenoprotein 
that is predicted to function as a thiol-
disulfide oxidoreductase (Ferguson et al., 
2006). It contains a thioredoxin-like fold 
and a conserved CxxU active-site motif, 
which is characteristic of enzymes involved 
in the regulation of redox processes 
(Martin, 1995). We recently carried out an 
expressed sequence tag (EST) project to 
identify genes and pathways involved in 
skeletal development. As a result, we ob-
served that Selm was overrepresented in 
human growth plate tissue (Tagariello et al., 
2005). However, although SELM is thought 
to be involved in oxidative stress (Hwang et 
al., 2008; Yim et al., 2009; Garcia-Triana et 
al., 2010) and Alzheimer's disease (Hwang 
et al., 2005), the expression pattern and tis-
sue-specific function of Selm remain un-
known. 
In the present study, we describe for the 
first time prominent Selm expression in 
bony structures and tendons of the develop-
ing chicken and mouse. The present data 
suggest that SELM may play a role in the 
proper folding and processing of secreted 
proteins during bone development. 
 
RESULTS AND DISCUSSION 
We first analyzed the expression pattern 
of SELM by RNA in situ hybridization. Due 
to an easier handling and better availability 
(especially of early stages), tissue sections 
of chicken wings aged 6 days (Hamburger 
Hamilton stage 29; HH29) to 14 days 
(HH40) were used (Figure 1A). At HH29 
we observed SELM expression in the con-
densed mesenchyme that will develop into 
bone. In later developmental stages promi-
nent expression in bones could be detected. 
This could be verified by detailed compara-
tive analysis of serial sections of wings 
HH40 with different markers (Figure 1B, 
C). The SELM expression pattern largely 
coincides with that of osteocalcin (BGLAP) 
and also with alkaline phosphatase (AP), 
two markers for osteoblasts (Ducy and 
Karsenty, 1995; Schinke and Karsenty, 
1999; Franz-Odendaal et al., 2006). These 
results suggest expression in osteoblasts. To 
exclude expression in chondrocytes and 
verify expression in osteoblasts, we carried 
out a semiquantitative PCR with cDNA of 
different cell types (Figure 2). In chicken 
micromass cultures, differentiated to chon-
drocytes for seven days, no SELM expres-
sion could be detected (Figure 2A). The 
chondrocyte phenotype was verified by 
type II (COL2A1) and type X (COL10A1) 
collagen, two markers for chondrocytes 
(Lefebvre and Smits 2005). In contrast, ex-
pression of selm could be detected in prima-
ry osteoblasts prepared from chicken cal-
variae and differentiated for 21 days (Fig-
ure 2B). Also in the murine pre-osteoblastic 
cell line MC3T3 (differentiated for 30 days) 
Selm could be detected together with the 
osteoblast markers Osteocalcin (BGLAP) 
and type I collagen (COL1A1) (Figure 2C).  
Additional to expression in osteoblasts, 
we also observed expression in tendons. By 
RNA in situ hybridization of wings of dif-
ferent developmental stages we detected 
coexpression of SELM, scleraxis (SCX), and 
tenomodulin (TNMD) (Figures 3, 4). Since 
SCX and TNMD are specifically expressed 
in tenocytes (Blitz et al., 2009), our results 
demonstrate expression of SELM in this cell 
type. 
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Figure 1: SELM expression in long bones during chicken development 
RNA in situ hybridization on 5 µm thick paraffin sections of wings of indicated developmental stages 
(A) and wings at stage HH40 (B).  
(A) Sections were hybridized with antisense riboprobes against SELM. Scale bar, 1 mm. 
(B, C) Serial sections were hybridized with antisense riboprobes against SELM and BGLAP, an addi-
tional Azan and alkaline phosphatase (AP) staining is shown. Scale bar, 1 mm (B), 50 µm (C). 
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Figure 2: SELM expression in osteoblasts 
Semiquantitative RT-PCR analysis of SELM expression in chicken micromass cultures (A), primary 
osteoblasts prepared from chicken calvariae HH41 (B) and in the murine pre-osteoblast cell line 
MC3T3 (C). Additional genes (as indicated) were used to verify the cell type, Gapdh served as loading 
control. 
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Figure 3: Expression of SELM in tendons during chicken development 
RNA in situ hybridization on 5 µm thick paraffin sections of wings of indicated developmental stages. 
Serial sections were hybridized with antisense riboprobes against SELM, SCX and TNMD, an addi-
tional Azan staining is shown. Scale bar, 2 mm. 
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Figure 4: SELM expression in tenocytes 
RNA in situ hybridization on 5 µm thick paraffin sections of legs at stage HH38. Serial sections were 
hybridized with antisense riboprobes against SELM, SCX and TNMD, an additional Azan staining is 
shown. One tendon is marked by an arrow. Scale bar, 2 mm (A), 50 µm (B).  
 
 
To verify and further support the strong 
expression pattern of SELM especially in 
the developing bone we used another spe-
cies and subsequently analyzed Selm ex-
pression on murine tissue sections by RNA 
in situ hybridization. On embryonic day 
E16.5, Selm was prominently expressed in 
the bones of the craniofacial, axial, and ap-
pendicular skeleton (Figure 5). In particu-
lar, expression in the vertebrae, maxilla, 
and mandibula could be detected (Figure 
5A) as well as in the trabecular bone and 
the periosteum of long bones (Figure 5B 
and data not shown). This expression pat-
tern largely coincides with that of Bglap 
(Figure 5A). In addition, we also observed 
expression of Selm in the olfactory epitheli-
um at this developmental stage (Figure 5A). 
We subsequently analyzed expression of 
Selm in the head and limb sections of 4-
day-old mice (P4) (Figure 6). Strong ex-
pression of Selm was detected in the cere-
bellum and olfactory epithelium, and to a 
lesser extent in the hippocampus (Figure 
6A). These results corroborate the recent 
findings of a study by Zhang et al. (2008), 
which demonstrated elevated Selm expres-
sion in the cerebellum, olfactory bulb, 
Ammon's horn, and hippocampus. We 
found additional expression in the teeth and 
bones that resembled the expression pattern 
of Bglap (Figure 6A). Moreover, expression 
of Selm was observed in the periosteum and 
trabecular bone of P4 hindlimb sections 
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(Figure 6B). Comparison of the expression 
pattern of Selm with that of markers for ear-
ly (Col1a1) and late (Bglap) osteoblasts 
(Jikko et al., 1999; Cohen, 2006; Kulterer et 
al., 2007), revealed overall coexpression of 
Selm and Col1a1. In contrast, coexpression 
of Selm and Bglap was restricted to the pe-
riosteum (Figure 6B). 
 
 
 
 
Figure 5: Expression of Selm in fetal mice (E16.5) 
RNA in situ hybridization on 5 µm thick paraffin sections of whole embryos (A) and hindlimbs (B). 
Scale bar, 2 mm.  
(A) Sections were hybridized with antisense riboprobes against Selm and Bglap as indicated. Verte-
brae are marked by an arrow. md, mandibula; mx, maxilla; oe, olfactory epithelium. 
(B) Sections were hybridized with antisense riboprobes against Selm, an additional Azan staining is 
shown. Pe, periosteum; tb, trabecular bone; ti, tibia. 
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Figure 6: Expression of Selm in juvenile mice (P4) 
RNA in situ hybridization on 5 µm thick paraffin serial sections of the head of postnatal day 4 (P4) 
mice (A; scale bar, 1 mm) and hindlimbs (B; scale bar, 0.5 mm). Sections were hybridized with anti-
sense riboprobes against Selm, Bglap, and Col1a1, and stained with Azan as indicated. (C) Magnified 
views of the corresponding boxed areas in B. cb, cerebellum; fe, femur; fi, fibula; hi, hippocampus; 
mo, molar; mx, maxilla; nc, nasal concha; oe, olfactory epithelium; sb, sphenoid bone; tb, trabecular 
bone, ti, tibia; pe, periosteum; vn, vomeronasal organ. 
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Since strong Selm expression was ob-
served in osteoblasts during bone develop-
ment, we aimed to elucidate potential func-
tions of SELM in osteoblasts in vivo. We 
generated a mutant mouse strain from ES 
cells (C57BL/6) containing a genetic dele-
tion of Selm (Selm-/-; Supplementary Figure 
1). The open reading frame (ORF) of Selm 
in these ES cells was replaced with a ZEN-
Ub1 cassette that contains a LacZ reporter 
gene under transcriptional control of the 
endogenous gene promoter. Although com-
plete loss of Selm expression was verified 
by RNA in situ hybridization and real-time 
PCR (Supplementary Figure 1), Selm defi-
ciency did not affect viability or fertility. 
Moreover, morphological and histological 
analyses did not reveal any visible skeletal 
abnormalities, indicating that Selm defi-
ciency may be compensated by other sele-
noproteins. Nevertheless, we used the 
Selm-/- mice to verify the expression pattern 
of Selm by X-Gal staining of E16.5 (Figure 
7A) and P4 (Figure 7B) mice, which ex-
press β-galactosidase under the control of 
the Selm promoter (Supplementary Fig-
ure 1). As shown in Figure 7A (e, f) com-
parative Alizarin red and Alcian blue stain-
ing for visualization of bone and cartilage, 
respectively, confirmed expression of Selm 
in almost all bony structures of the skele-
ton. 
 
Figure 7: X-Gal staining 
(A) X-Gal staining of E16.5 Selm-/- (a, b) and wild type mice (c, d). Wild type embryos were simultane-
ously stained with Alizarin red and Alcian blue to visualize bone and cartilage, respectively (e, f). Cal-
varial bones are marked by arrows. Scale bar, 2 mm. 
(B) X-Gal staining of P4 wild type (+/+) and Selm-/- mice (-/-). Staining of the head (b), hindlimb (c), 
and ribs (d) of Selm-/- mice is shown in detail. Scale bar, 5 mm. 
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The present study is the first to analyze 
SELM expression in chicken and mouse 
sections during development and to link 
SELM with bone and tendon development. 
The ER-localized SELM protein possesses 
(1) a thioredoxin-like domain, (2) a surface-
accessible active-site redox motif, and (3) 
structural similarities to other characterized 
thiol-disulfide oxidoreductases (Korotkov 
et al., 2002), suggesting that SELM repre-
sents a thiol-disulfide isomerase that is in-
volved in disulfide bond formation in the 
ER (Ferguson et al., 2006). Moreover, the 
high expression level of SELM in osteo-
blasts and tenocytes — the main matrix 
producing cells of bones and tendons, re-
spectively — indicates that SELM plays a 
role in the processing of ECM proteins. The 
ER is the site of synthesis and processing of 
secretory pathway proteins, which include 
transmembrane proteins and constituents of 
the extracellular matrix. In osteoblasts and 
tenocytes, vast amounts of ECM proteins, 
particularly the fibrillar collagens COL1A1 
and COL1A2, are synthesized and secreted. 
Correct folding is a prerequisite for exiting 
the ER, whereas misfolded proteins are re-
tained. Accumulation of misfolded or un-
derglycosylated proteins results in ER stress 
— a process that has been shown to play a 
fundamental role in the initiation and pro-
gression of a wide range of connective tis-
sue disorders (Boot-Handford and Briggs 
2010). Together with observations demon-
strating an involvement of SELM in un-
folded protein response (UPR) and ER 
stress (Grosch et al., unpublished), the data 
indicate that SELM may play a role in the 
proper folding and processing of secreted 
proteins during bone and tendon develop-
ment. 
 
EXPERIMENTAL PROCEDURES 
Ethics statement 
All mouse experiments were approved 
by the Ethics Committee for Animal Exper-
iments of the University of Erlangen (TS-
05/10). 
 
RNA in situ hybridization 
RNA in situ hybridization on 5 µm par-
affin sections of chicken or mouse tissue 
using digoxigenin-labeled antisense ribo-
probes for Selm, Col1a1, and Bglap was 
carried out as previously reported (Schmidl 
et al., 2006). Specific cDNA fragments for 
murine Selm (NM_053267) and Bglap 
(NM_001032298) antisense riboprobes 
were obtained by RT-PCR 
 (Selm, 5′-ttcttgcagcccttgtggctcc-3′ and 
5′-acttgcggtagaagccgagc-3′;  
 Bglap, 5′-catgaggaccctctctctgc-3′ and 5′-
tgccagagtttggctttagg-3′) and cloned into 
pCRII-TOPO and pCR4-TOPO vectors, 
respectively. Specific cDNA fragments 
for chicken SELM, BGLAP 
(NM_205387), SCX (NM_204253) and 
TNMD (NM_206985) antisense ribo-
probes were obtained by RT-PCR  
 (SELM, 5′-gcggtgggtgacggctgagccgg-3′ 
and 5′-ttacaggtctgggtggtccttcttg-3′; 
 BGLAP, 5′-gctcacattcagcctctgc-3′ and 5′-
ggagaagtggagcataatgg-3′; 
 SCX, 5′-agctgtccaagatcgagacg-3′ and 5′-
gtgaagacgggagtgtgtcc-3′;  
 TNMD, 5′-accttcaggagtgggaacg-3′ and 
5′-tccgtgtagtcgttgacagg-3′) and cloned 
into the pCR4-TOPO vector. The 
Col1a1 plasmid was a kind gift from Dr. 
Michael Stock. 
 
Cell culture 
The pre-osteoblast murine cell line 
MC3T3 (ATCC) was cultivated in alpha 
modified Eagle's medium supplemented 
with 10 % FCS and 100 U/ml penicillin/ 
streptomycin at 37 °C and 5 % CO2. Cells 
were differentiated for 30 days by adding of 
50 mg/ml ascorbic acid and 50 mg/ml glyc-
erol-2-phosphate to the culture medium. 
 
Micromass cultures 
Micromass cultures were prepared from 
chicken limb buds (HH22-24) by digestion 
with 3 mg/ml dispase followed by treatment 
with 0.1 % collagenase Ia and 0.1 % tryp-
sin. Cells were cultivated in DMEM:F-12 
(1:1) supplemented with 10 % FCS, 0.2 % 
CS and 100 U/ml penicillin/streptomycin at 
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37 °C and 5 % CO2. Culture medium was 
changed every day.  
 
Primary osteoblasts 
Primary osteoblasts were prepared from 
the calvariae of chicken (HH41). Chicken 
calvariae were digested with 1,5 U/ml col-
lagenase P and 0,05 % trypsin.  
Primary osteoblasts were cultivated in 
alpha modified Eagle's medium supple-
mented with 10 % fetal calf serum (FCS) 
and 100 U/ml penicillin/streptomycin in 6-
well plates at 37 °C and 5 % CO2. The cul-
ture medium was changed every 3 days. 
When the cells reached confluency, they 
were differentiated for 21 days by adding of 
50 mg/ml ascorbic acid and 50 mg/ml glyc-
erol-2-phosphate to the culture medium. 
 
RT-PCR 
Total RNA was isolated from cells us-
ing TRIzol (Invitrogen). First-strand cDNA 
was synthesized with oligo(dT) primer and 
Superscript III Reverse Transcriptase (Invi-
trogen), according to manufacturer's in-
structions.  
To verify the osteoblast or chondrocyte 
phenotype of cell cultures, semiquantitative 
RT-PCR with following primers was car-
ried out  
 (COL1A2, 5′-gcaacattggattccctggacc-3′ 
and 5′-gttcacccttttctcccttgcc-3′;  
 COL2A1, 5′-ccaacaccgccagcatcc-3′ and 
5′-gccaatatccacgccaaactcct-3′;  
 COL10A1, 5′-gccaatatccacgccaaactcct-3′ 
and 5′-cagaggaatagagaccat-3′;  
 COL12A1, 5′-gcagaaccaaacctctcact-3′ 
and 5′-ttcttggtgttcctctctcc-3′; 
 SELM, 5′-gcggtgggtgacggctgagccgg-3′ 
and 5′-ttacaggtctgggtggtccttcttg-3′;  
 Bglap, 5′-catgaggaccctctctctgc-3′ and  
5′-tgccagagtttggctttagg-3′;  
 Col1a1, 5′-cctggtaaagatggtgcc-3′ and 5′-
caccaggttcacctttcgcacc-3′;  
 Selm, 5′-ttcttgcagcccttgtggctcc-3′ and 5′-
acttgcggtagaagccgagc-3′).  
 Gapdh was used as control (GAPDH,  
5′-gtggagtccactggtgtcttc-3′ and  
5′-atcagcagcagccttcactac-3′;  
 Gapdh, 5′-gtggagtccactggcgtcttc-3′ and 
5′-ctccgacgcctgcttcaccac-3′).  
 
Alcian blue and Alizarin red staining 
Whole E15.5 embryos or skinned and 
eviscerated P4 mice were fixed in 95 % 
EtOH for 1–2 days. Mice were moved into 
glass vials and immersed in acetone over-
night at room temperature. Subsequently, 
mice were rinsed in 95 % EtOH and stained 
for cartilage in Alcian blue (0.015 % Alcian 
blue 8GX, 76 % EtOH, and 20 % glacial 
acid). After washing with 95 % EtOH over-
night and clearing in 1 % KOH (embryo) or 
2 % KOH (P4), mice were stained in 
0.005 % Alizarin red S in 1 % KOH for 3 to 
6 h. For clearing of stained mice, samples 
were incubated in 5 % KOH for 5 days fol-
lowed by a series of clearing solutions con-
taining increasing glycerol and decreasing 
KOH concentrations (80:20, 60:40, 40:60, 
20:80; 1 % KOH:glycerol). Finally, sam-
ples were stored in 100 % glycerol. 
 
X-Gal staining 
Whole E15.5 embryos or skinned and 
eviscerated P4 mice were fixed in 4 % para-
formaldehyde for 1 h at 4°C. After 3 wash-
ing steps in pre-washing solution (1× PBS 
and 2 mM MgCl2) at 4°C, samples were 
incubated twice for 15 min at room temper-
ature (RT) in detergent solution (1× PBS, 
2 mM MgCl2, 0.02 % NP-40, and 0.01 % 
Na-deoxycholate) before incubation at RT 
with staining solution (1× PBS, 20 mM 
Tris-HCl [pH 7.5], 2 mM MgCl2, 0.02 % 
NP-40, 0.01 % Na-deoxycholate, 5 mM 
K3Fe(CN)6, 5 mM K4Fe(CN)6, and 
0.75 mg/ml X-Gal in DMSO) under visual 
observation. Subsequently, samples were 
washed 3 times in post-washing solution 
(1× PBS and 5 mM EDTA, pH 8) and post-
fixed overnight at 4°C in 4 % paraformal-
dehyde. For clearing of X-Gal stained mice, 
samples were incubated in 5 % KOH for 5 
days followed by a series of clearing solu-
tions containing increasing glycerol and 
decreasing KOH concentrations (80:20, 
60:40, 40:60, 20:80; 1 % KOH:glycerol). 
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Finally, samples were stored in 100 % 
glycerol. 
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